Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Post-Vaccination Yellow Fever Antibodies Enhance Zika Virus Infection in Embryoid Bodies

Version 1 : Received: 6 July 2020 / Approved: 7 July 2020 / Online: 7 July 2020 (02:29:39 CEST)

How to cite: Schultz, E.M.; Jones, T.J.; Barr, K.L. Post-Vaccination Yellow Fever Antibodies Enhance Zika Virus Infection in Embryoid Bodies. Preprints 2020, 2020070105 (doi: 10.20944/preprints202007.0105.v1). Schultz, E.M.; Jones, T.J.; Barr, K.L. Post-Vaccination Yellow Fever Antibodies Enhance Zika Virus Infection in Embryoid Bodies. Preprints 2020, 2020070105 (doi: 10.20944/preprints202007.0105.v1).

Abstract

Zika virus (ZIKV) is a flavivirus that originated in Africa but emerged in Latin America in 2015. In this region, other flaviviruses such as Dengue (DENV), West Nile, and Yellow Fever Virus (YFV) also circulate, allowing for possible antigenic cross-reactivity to impact viral infections and immune responses. Studies have found antibody mediated enhancement between DENV and ZIKV, but the impact of YFV antibodies on ZIKV infection has not been fully explored. ZIKV infections cause congenital syndromes, such as microcephaly, necessitating further research into ZIKV vertical transmission through the placental barrier. Recent advancements in biomedical engineering have generated co-culture methods that allow for in vitro recapitulation of the maternal: fetal interface. This study utilized a transwell assay, which is a co-culture model utilizing human placental syncytiotrophoblasts, fetal umbilical cells, and a differentiating embryoid body to replicate the maternal: fetal axis. To determine if cross reactive YFV vaccine antibodies impact the pathogenesis of ZIKV across the maternal fetal axis, maternal syncytiotrophoblasts were inoculated with ZIKV or ZIKV incubated with YFV vaccine anti-sera, and viral load was measured 72 hours post inoculation. Here we report that BeWo and HUVEC cells are permissive to ZIKV and that the impact of YFV post-vaccination antibodies on ZIKV replication is cell line dependent. Embryoid bodies are also permissive to ZIKV and the presence of YFV antibodies collected 1 to 6 months post vaccination enhances ZIKV infection. Our data show that each of the cell lines and EBs have a unique response to ZIKV complexed with post-vaccination serum suggesting there may be cell-specific mechanisms that impact congenital ZIKV infections. Since ZIKV infections can cause severe congenital syndromes, it is crucial to understand any potential enhancement or protection offered from cross-reactive, post-vaccination antibodies.

Subject Areas

Zika virus; yellow fever virus; cross-reactivity; neutralization; enhancement; zika congenital syndrome; stem cells

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.